Translational study reveals that DTL overexpression promotes proliferation and predicts poor survival in esophageal cancer, highlighting its role as a prognostic marker and therapeutic target.
Topic Esophageal Cancer: Molecular Biology/Pathology Background Comparative genomic hybridization (CGH) method has contributed to the analysis of amplification and deletion of various genes. We detected Denticleless E3 ubiquitin protein ligase homolog (DTL) using the Agilent 244k oligo-array CGH and FISH analyses for 1q32 amplification among 22 genes in esophageal squamous cell carcinoma (ESCC) and investigated DTL as a cancer promoting gene. Methods We analyzed 43 ESCC cell lines and 113 primary ESCC samples. Results 1) Overexpression of DTL mRNA was detected 100% (43/43) in ESCC cell lines compared to normal esophageal tissue. Knockdown of DTL expression drastically inhibited cell proliferation, induced G2/M arrest and inhibited migration and invasion. 2) Immunohistochemically, no expression was detected in normal esophageal tissue. Overexpression of DTL was detected in 26.5% (30/113) of ESCC tumors, and correlated with advanced N-stage. DTL positivity was an independent poor prognostic factor in multivariate analysis (P=0.035, hazard ratio 2.1). Conclusion DTL plays a crucial role in malignant potential through overexpression, highlighting its utility as a prognostic factor, and a novel therapeutic target in ESCC.
No takes yet. Share an insight, caveat, or question.
YAMAUCHI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: